Outlook Therapeutics, Inc. (OTLK) Net margin 2016–2025
Outlook Therapeutics, Inc. (OTLK) net profit margin by fiscal year — reported net income divided by reported revenue.
-4416.2%FY2025 · since FY2016: -1788.9% → -4416.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4416.2% | — |
| FY2019 | -423.8% | +550.8 pp |
| FY2018 | -974.6% | +44.6 pp |
| FY2017 | -1019.3% | +769.7 pp |
| FY2016 | -1788.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice